Page last updated: 2024-09-02

fingolimod hydrochloride and lamivudine

fingolimod hydrochloride has been researched along with lamivudine in 1 studies

Compound Research Comparison

Studies (fingolimod hydrochloride)	Trials (fingolimod hydrochloride)	Recent Studies (post-2010) (fingolimod hydrochloride)	Studies (lamivudine)	Trials (lamivudine)	Recent Studies (post-2010) (lamivudine)
2,771	157	2,062	7,025	1,425	2,177

Protein Interaction Comparison

Protein	Taxonomy	fingolimod hydrochloride (IC50)	lamivudine (IC50)
Capsid protein	Hepatitis B virus		0.1

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brescia Morra, V; De Rosa, A; Matarazzo, M; Pane, C; Saccà, F	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and lamivudine

Article	Year
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017, Volume: 38, Issue:3 Topics: Adult; Female; Fingolimod Hydrochloride; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Reverse Transcriptase Inhibitors	2017

Article

Year

Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017, Volume: 38, Issue:3

Topics: Adult; Female; Fingolimod Hydrochloride; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Reverse Transcriptase Inhibitors

2017